Nogapendekin alfa inbakicept with BCG for non-muscle-invasive bladder cancer with carcinoma in situ that is unresponsive to BCG (terminated evaluation)
Technology appraisal
Reference number: TA1163
Published:
Nogapendekin alfa (ALT-803) + Intravesical Bacillus Calmette-Guerin (BCG) within
its marketing authorisation for treating bladder cancer